Pharm Advertising Reduction Of Malpractice One Of Essay

Length: 6 pages Sources: 30 Subject: Medicine Type: Essay Paper: #9526730 Related Topics: Medical Malpractice, Pharmaceutical Industry, Physician, Advertising
Excerpt from Essay :

Pharm Advertising

Reduction of Malpractice

One of the key manners in which direct-to-physician advertising of pharmaceuticals can lead to health promotion is in the reduction of malpractice on the part of physicians when it comes to the administering of pharmaceuticals. It is of course the primarily (and ultimately, solely) the physicians' responsibility to ensure the proper and effective use of pharmaceutical products, just as it is their responsibility to ensure that all care practices and interventions are in the best interests of the patient. Pharmaceutical companies have this goal and this responsibility as well, however, and they can be instrumental in making sure that true best interests are served with current knowledge of best practices and new potentials. As advertising is ultimately the provision of information, it can be seen that the direct advertising of pharmaceuticals to physicians can provide more comprehensive, detailed, and current information regarding new products, new uses, and the risks and benefits of specific pharmaceutical agents. The direct advertising constitutes an information-sharing relationship, and arming physicians with better information can only serve to assist them in their quest to achieve the best results for their patients (Schwartz et al., 2009).

While concerns have been raised about direct and even indirect financial relationships between pharmaceutical companies/drug representatives and physicians, it has also been noted that physicians can depend on the information provided by drug representatives to make decisions based on the most current available information (Matthews, 2007; Schwartz et al., 2009). At the same time, not all or even most physicians recognize the level of influence that the information provided by pharmaceutical companies in regards to their products can have on the prescription habits of physicians, though these influences have been measured and reported in numerous studies (Matthews, 2007). Promoting physician awareness of pharmaceutical advertising as a means of gathering relevant information and then consciously applying this information could help them make more effective decisions and provide greater clarity and transparency in the pharmaceutical representative/physician relationship, both of which could lead to greater levels of health promotion in patients and therefore reduced incidence and accusations of malpractice.

Direct-to-physician advertising need not only be utilized in the promotion of more effective pharmaceutical use in terms of encouraging prescription use, but also when it comes to preventing misuse of prescriptions. Off-label prescribing has been a major concern in the medical community and advertising off-label uses has been strictly prohibited by law, and thus any direct-to-physician advertising would necessarily be directed towards encouraging the proper and approved use of pharmacological agents, which would necessarily discourage off-label uses and prescriptions (Klasmeier & Redish, 2011). In this manner, direct-to-physician advertising works to limit potential malpractice claims and accusations as well as truly negative events from both ends, promoting the effective and proper use of medications and defining the limits of use to ensure that medications are not prescribed for situations that they are not suited to. This relates directly to one of the most pressing ways in which direct-to-physician advertising can reduce malpractice: the presentation of research.

Pharmaceutical advertising that appears in medical journals affects malpractice potentials in two primary ways. First, the advertising itself typically contains detailed information about the specific pharmacological agents being advertised, including the results of evaluational research conducted in clinical trials and practice, providing in a concise and widely-read and -- disseminated form all of the information that a physician needs to make a responsible and effective decision based on the information that is currently available (Rotfield & Taylor, 2009). This direct-to-physician advertising is actually far more preferable to direct-to-consumer advertising in terms of ensuring that proper decisions are being made, and that malpractice potentials are being reduced or avoided through the increased knowledge and competence of the decision makers (Nguyen, 2010). Second, the pharmaceutical advertising published in medical journals is a major source of the revenue that these journals need in order to remain operational, and so in a slightly indirect manner the pharmaceutical industry and the direct-to-physician advertising it engages in are responsible for maintaining adequate levels of information flowing within the medical community, which has a profound impact on health promotion and the ability of physicians to reduce malpractice potential through the


The research contained in these journals covers all imaginable medical issues and areas, and thus it is clear that direct-to-physician advertising promotes the use of evaluational research in clinical practice.

Cost Analysis in Direct-to-Physician Advertising

There are other ways that direct-to-physician advertising can alter malpractice potentials and otherwise alter physician and overall medical community performance when it comes to prescribing medications. Cost controls are an important feature of medical practice for patients and medical institutions alike, and ineffective prescription, over-prescription, or other unintentional misuses of pharmacological and inefficiencies in prescription practices can lead to overspending and reductions in the cost-effectiveness of medications. Some studies have found that direct-to-physician advertising by pharmacological companies actually lowers prescription costs for physicians, a finding which has several implications (Spurling et al., 2010). First, it can be seen that pharmacological advertising includes information that is at least tangentially related to prescription costs, to a high enough degree to affect physician thinking and decision-making in regards to the writing of prescriptions. Second, the specific findings in regards to this observed cost reductions are not especially wide-spread and could likely be made more significant and more prevalent if a more direct and conscious effort to provide cost analyses in pharmaceutical advertising was made by the pharmaceutical companies (Spurling et al., 2010).

Interestingly, a study of general practice physician outcomes and trends in England found no statistically significant correlation between prescription costs and the quality of patient outcomes; that is, lower prescriptions costs were not consistently associated with a higher overall quality of care and health promotion, nor were they associated with lower qualities of care (Fleetcroft et al., 2011). This suggests that there are a multitude of factors involved in the relationship between prescription cost and health promotion when it comes to pharmaceuticals, with direct implications on direct-to-physician advertising. If advertising has been associated with lower prescription costs but these lower costs are not associated with higher levels of care quality, health promotion, and ultimate outcomes, though, this advertising is not as effective as it potentially could be. To make matters even more pressing, other research has demonstrated that there might actually be a negative correlation between exposure to direct-to-physician advertising and the overall quality of prescribing behaviors in some physicians (Spurling et al., 2010). Though this finding has only emerged in a very small number of studies from a rather large body of research that has examined the issue, it is enough to suggest that more direct attention needs to be paid to associating cost effectiveness with quality outcomes in direct-to-physician advertising, maximizing the potential for increasing health promotion through this method of information provision.

Well-informed physicians are capable of making better and more consistent decisions; this fact is essentially self-evident and is of paramount importance in developing and effectively utilizing direct-to-physician advertising by pharmaceutical companies. Less self-evident but equally important is the observation made in current research that well-informed physicians are more capable of controlling prescription costs in a much more consistent manner than other patient and clinical settings (Aguado et al., 2008). In a comparison of physicians to adjusted clinical groups and other group settings in medical centers, it was found that physicians achieved lower prescription costs than other settings with the same basic level of health promotion and quality of care, meaning that cost benefits can be achieved for patients and fro medical institutions by both making sure that physicians remain well-informed in regards to pharmacological practices and opportunities and that they are given the necessary latitude in decision-making to take full advantage of the knowledge they obtain from various sources. Direct-to-physician advertising can be a significant and meaningful source of this information if it is properly designed and developed, providing clear and concise assessments of costs and needs that might warrant certain prescriptions at higher costs, or even suggesting alternatives that might be cheaper and still appropriate in certain situations.

The increasing prominence of direct-to-consumer advertising by pharmacological companies has implications that encourage the presenting of cost analyses in direct-to -- physician, as well. Though there are both benefits and risks to direct-to-consumer advertising, one of the most consistent features of this advertising that has been noted is the lack of true need and benefit appraisal by consumers when considering pharmacological treatments (Frosch et al., 2010). Physicians are in a much better position to make such appraisals, but are often less directly aware of and concerned with costs than patients. Including cost analysis information in direct-to-physician advertising would help to rectify this difference in awareness and focus and lead to even more effective considerations and decisions by physicians in regards to the cost benefits of utilizing certain prescriptions.


Aguado, A., Guino, E., Mukherjee, B., Sicras, A…. & Moreno, V. (2008). BMC Health Services Research 8(1):…

Sources Used in Documents:


Aguado, A., Guino, E., Mukherjee, B., Sicras, A…. & Moreno, V. (2008). BMC Health Services Research 8(1): 53.

Fleetcroft, R., Cookson, R., Steel, N. & Howe, A. (2011). Correlation between prescribing quality and pharmaceutical costs in English primary care: national cross-sectional analysis. British Journal of General Practice 61(590): 556-64.

Frosch, D., Grande, D, Tarn, D. & Kravitz, R. (2010). A Decade of Controversy: Balancing Policy With Evidence in the Regulation of Prescription Drug Advertising. American Journal of Public Health 100(1): 24-32.

Gagnon, M. & Lexchin, J. (2008). The Cost of Pushing Pills: A New Estimate of Pharmaceutical Promotion Expenditures in the United States. PLoS Medicine 5(1).

Cite this Document:

"Pharm Advertising Reduction Of Malpractice One Of" (2012, January 11) Retrieved June 12, 2021, from

"Pharm Advertising Reduction Of Malpractice One Of" 11 January 2012. Web.12 June. 2021. <>

"Pharm Advertising Reduction Of Malpractice One Of", 11 January 2012, Accessed.12 June. 2021,

Related Documents
Nuclear Medicine the Recent Nuclear Crisis Suffered
Words: 1736 Length: 5 Pages Topic: Medicine Paper #: 47785622

Nuclear Medicine The recent nuclear crisis suffered by Japan seems to justify the fear-mongering much of the mainstream media engages in regarding the use of nuclear energy. Yet, many experts know that "nuclear imaging is used on tens of thousands of patients every day to take pictures of their hearts, lungs, kidneys, bones, brains and other organs" (Walters, 2009, p. 33) with very little adverse reactions to the procedure(s). Oftentimes the

Impact of Nuclear Medicine Exposures to the American Population
Words: 4415 Length: 14 Pages Topic: Disease Paper #: 81766708

Health Threat of Medical Ionizing Radiation Impact of Nuclear Medicine Exposures In October 2009, the U.S. Food and Drug Administration (FDA) alerted all healthcare facilities involved in performing brain perfusion computed tomography (CT) to ensure their patients were not being overexposed to ionizing radiation (Samson, 2009). This notice was in response to the discovery that 206 patients subjected to this procedure at the Cedars-Sinai Medical Center in Los Angeles had been exposed

Incidental Findings in Nuclear Medicine Scans
Words: 2832 Length: 10 Pages Topic: Anatomy Paper #: 40309725

Thyroid "hot spots" incidentally detected by whole body Fluorodeoxyglucose-Positron Emission Tormography (FDG-PET) scan Fluorodeoxyglucose (FDG) whole body positron emission tormography (PET) scan is being used more often in the diagnostic follow-up or work-up of patients. In such conditions, positive PET scans with unanticipated hot spots within the thyroid region could be given the definition of thyroid FDG-PET incidentaloma, a name analogous to unexpected sonographic thyroid modules. A description of eight consecutive

Nuclear Weapons Knowing Why States Build Nuclear
Words: 2096 Length: 6 Pages Topic: Military Paper #: 57353318

Nuclear Weapons Knowing why states build nuclear weapons is important for us in order to determine the future of international security and to direct foreign policy efforts in such a way so as to limit the spread of such dangerous armaments. Nuclear weapons are explosives which derive their ability to destroy from chemical reactions, either fission or fusion or a combination of both reactions. These reactions release an enormous quantity of

Nuclear Weaponry Nuclear Weapons Have Had a
Words: 1947 Length: 6 Pages Topic: Drama - World Paper #: 53947484

Nuclear Weaponry Nuclear weapons have had a profound impact upon the world at large, as well as upon the United States of America, since they were researched and created within the middle of the 20th Century. The political ramifications of the possession of, monitoring of, and even the occasional use of such weapons have drastically influenced the way nation states conduct themselves towards one another. There was a prolonged time period

Nuclear Power for Energy and
Words: 4593 Length: 10 Pages Topic: Energy Paper #: 569960

This can merely be helpful on local level but not at all on the global level. Radioactive materials in low quantities are present in fossil fuels, chiefly in coal and using them in heavy amounts can have more hazardous effects on the environment causing radioactive contamination globally. This is a much more pressing concern when compared to the radioactive contamination within a nuclear power station as the noxious waste in